Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION Trial

Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION Trial

Background: The surveillance of non-muscle invasive bladder cancer (NMIBC) requires frequent cystoscopies, which are costly and uncomfortable for patients. Uromonitor is a validated non-invasive urinary test for detecting NMIBC recurrence. However, data on its clinical benefit in an NMIBC surveillan...

Full description

Bibliographic Details
Main Authors: Nessn Azawi, Juan Luis Vásquez, Thomas Dreyer, Cathrine Silberg Guldhammer, Rami Muthanna Saber Al-Juboori, Anna Munk Nielsen, Jørgen Bjerggaard Jensen
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Cancers
Subjects:
non-muscle invasive bladder cancer
Uromonitor<sup>®</sup>
urinary test
surveillance
follow-up cystoscopy
low-grade recurrence
Online Access:https://www.mdpi.com/2072-6694/15/8/2341

Similar Items

Similar Items